GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY

Transcription

1 GNIPST BULLETIN th February, 2017 Volume No.: 64 Issue No.: 01 Vision To develop responsible citizens who would be professionally equipped to think globally and act locally and become reformers of society to meet the challenges of future. Mission To impart high quality pharmaceutical science, technology and management education to the budding professionals and provide the ambience needed for developing requisite skills to make a mark of excellence in Education, Research, Business, Industry and achieve highest personal standards. Contents Message from PRINCIPAL Editorial board Historical article News Update Knowledge based Article Disease Related Breaking News Upcoming Events Drugs Update Campus News Student s Section Editor s Note Archive GNIPST Photo Gallery For your comments/contribution OR For Back-Issues, mailto:gnipstbulletin@gmail.com GURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY W e bs i t e : ht t p: / / gni ps t. a c. i n

2 MESSAGE FROM PRINCIPAL "It can happen. It does happen. But it can't happen if you quit." Lauren Dane. We are what we repeatedly do. Excellence then is not an act, but a habit. Aristotle It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank the last year s editors and congratulate the newly selected editors for the current year. Our first consideration is always in the best interest of the students. Our goal is to promote academic excellence and continuous improvement. I believe that excellence in education is aided by creating a learning environment in which all learners are supported in maximizing their potential and talents. Education needs to focus on personalized learning and instruction, while promoting an education system that is impartial, universally accessible, and meeting the needs of all students. It is of paramount importance that our learners have sufficient motivation and encouragement in order to achieve their aims. We are all very proud of you, our students, and your accomplishments and look forward to watching as you put your mark on the profession in the years ahead. The call of the time is to progress, not merely to move ahead. Our progressive Management is looking forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken in this direction and fruits of these efforts will be received by our students in the near future. Our Teachers are committed and dedicated for the development of the institution by imparting their knowledge and play the role of facilitator as well as role model to our students. The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positive challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holistic needs of our students. I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of the opportunities and meet the challenges with purpose and determination. Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us on this path. My best wishes to all. Dr. A. Sengupta 1

3 EDITORIAL BOARD CHIEF EDITOR DR. ABHIJIT SENGUPTA EDITOR MS. JEENATARA BEGUM ASSOCIATE EDITOR MR. DIPANJAN MANDAL HISTORICAL ARTICLE Werner Heisenberg Werner Heisenberg was a German physicist and philosopher who is noted for his crucial contributions to quantum mechanics. He devised a method to formulate quantum mechanics in terms of matrices, for which he was awarded the 1932 Nobel Prize for Physics. Heisenberg is widely considered as one of the most influential figures in nuclear physics, particle physics and quantum field theory. Early Life and Education: Born in Würzburg, Germany in 1901, Werner Heisenberg s father was a prominent secondary school teacher. Heisenberg went to the Ludwig-Maximilians-Universität München and the Georg- August-Universität Göttingen, where he studied physics and mathematics from 1920 to He earned his doctorate in Contributions and Achievements: Werner Heisenberg ranks alongside Niels Bohr, Paul Dirac and Richard Feynman as far as his influence on contemporary physics is concerned. He was one of the most important figures in the development of quantum mechanics, and its modern interpretation. Heisenberg formulated the quantum theory of ferromagnetism, the neutron-proton model of the nucleus, the S-matrix theory in particle scattering, and various other significant breakthroughs in quantum field theory and high-energy particle physics are associated with him. As a prolific author, Heisenberg wrote more than 600 original research papers, philosophical essays and 2

4 explanations for general audiences. His work is still available in the nine volumes of the Gesammelte Werke (Collected Works). Heisenberg is synonymous with the so-called uncertainty, or indeterminacy, principle of 1927, for one of the earliest breakthroughs to quantum mechanics in 1925, and for his suggestion of a unified field theory, the so-called world formula. He won the Nobel Prize for Physics in 1932 at the young age of 31. Heisenberg stayed firmly in Germany during the worst years of the Hitler regime, heading Germany s research effort on the applications of nuclear fission during World War II. He also played a vital role in the reconstruction of West German science after the war. Heisenberg s role was crucial in the success of West Germany s nuclear and high-energy physics research programs. Later Life and Death: In his later years, Werner Heisenberg assumed various influential positions in Germany and abroad, giving important lectures on theoretical physics and other subjects. He died of cancer of the kidneys and gall bladder on February 1, Heisenberg was 74 years old. NEWS UPDATE Antibiotics could be alternative to surgery as treatment for appendicitis: (17 th February, 2017) Antibiotics may be an effective treatment for acute noncomplicated appendicitis in children, instead of surgery, a systematic review of existing literature concludes. Tumor suppressor promotes some acute myeloid leukemias, study reveals: (17 th February, 2017) A tumor suppressor protein thought to prevent acute myeloid leukemia (AML) can actually promote a particularly deadly form of the disease, researchers have discovered. The study suggests that 3

5 targeting this protein could be an effective treatment for certain AML patients. Powerful optical imaging technology catches DNA naturally fluorescing: (17 th February, 2017) Biomedical engineers have developed imaging technology that is the first to see DNA 'blink,' or fluoresce. The tool enables researchers to study individual biomolecules (DNA, chromatin, proteins) as well as important global patterns of gene expression, which could yield insights into cancer. Team tracks rare T cells in blood to better understand annual flu vaccine: (17 th February, 2017) A team has found a way to identify the small population of circulating helper T cells present in the blood after an annual flu vaccine to monitor their contribution to antibody strength. A technique that identifies these helper immune cells could inform future vaccine design, especially for vulnerable populations. Role of rogue protein PAK4 confirmed in pancreatic cancer cells: (17 th February, 2017) The role of a protein called PAK4 in the movement and growth of pancreatic cancer cells could help researchers find new ways to tackle the disease, a new study that confirms. Discovery of genetic 'switch' could help to prevent symptoms of Parkinson's disease: (17 th February, 2017) A genetic 'switch' has been discovered, which could help to prevent or delay the symptoms of Parkinson's disease, report scientists. 4

6 Stem cells collected from fat may have use in anti-aging treatments: (17 th February, 2017) Adult stem cells collected directly from human fat are more stable than other cells -- such as fibroblasts from the skin -- and have the potential for use in anti-aging treatments, according to researchers. Biocompatible 3-D tracking system has potential to improve robot-assisted surgery: (17 th February, 2017) The cutting-edge biocompatible near-infrared 3-D tracking system used to guide the suturing in the first smart tissue autonomous robot (STAR) surgery has the potential to improve manual and robot-assisted surgery and interventions through unobstructed 3- D visibility and enhanced accuracy, according to a new study. DNA computer brings 'intelligent drugs' a step closer: (17 th February, 2017) Researchers present a new method that should enable controlled drug delivery into the bloodstream using DNA computers. The team developed the first DNA computer capable of detecting several antibodies in the blood and performing subsequent calculations based on this input. This is an important step towards the development of smart, 'intelligent' drugs that may allow better control of medication with fewer side-effects and at lower cost. Mouse study reveals potential drug target for arthritis caused by chikungunya virus: (16 th February, 2017) An immune system proteinase called granzyme A appears to promote arthritic inflammation in mice infected with chikungunya virus, scientists report. The study also suggested that granzyme A could serve as a potential target for new drugs to treat chikungunya and related viral arthritides in people. 5

7 For detail mail to editor KNOWLEDGE BASED ARTICLE Drug to treat Duchenne muscular dystrophy The U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system. Corticosteroids are commonly used to treat DMD across the world. This is the first FDA approval of any corticosteroid to treat DMD and the first approval of deflazacort for any use in the United States. DMD is the most common type of muscular dystrophy. DMD is caused by an absence of dystrophin, a protein that helps keep muscle cells intact. The first symptoms are usually seen between 3 and 5 years of age and worsen over time. The disease often occurs in people without a known family history of the condition and primarily affects boys, but in rare cases it can affect girls. DMD occurs in about one of every 3,600 male infants worldwide. People with DMD progressively lose the ability to perform activities independently and often require use of a wheelchair by their early teens. As the disease progresses, life-threatening heart and respiratory conditions can occur. Patients typically succumb to the disease in their 20s or 30s; however, disease severity and life expectancy vary. The effectiveness of deflazacort was shown in a clinical study of 196 male patients who were 5 to 15 years old at the beginning of the trial with documented mutation of the dystrophin gene and onset of weakness before age 5. At week 12, patients taking deflazacort had improvements in a clinical assessment of muscle strength across a number of muscles compared to those taking a 6

8 placebo. An overall stability in average muscle strength was maintained through the end of study at week 52 in the deflazacorttreated patients. In another trial with 29 male patients that lasted 104 weeks, deflazacort demonstrated a numerical advantage over placebo on an assessment of average muscle strength. In addition, although not statistically controlled for multiple comparisons, patients on deflazacort appeared to lose the ability to walk later than those treated with placebo. The side effects caused by Emflaza are similar to those experienced with other corticosteroids. The most common side effects include facial puffiness (Cushingoid appearance), weight gain, increased appetite, upper respiratory tract infection, cough, extraordinary daytime urinary frequency (pollakiuria), unwanted hair growth (hirsutism) and excessive fat around the stomach (central obesity). Other side effects that are less common include problems with endocrine function, increased susceptibility to infection, elevation in blood pressure, risk of gastrointestinal perforation, serious skin rashes, behavioral and mood changes, decrease in the density of the bones and vision problems such as cataracts. Patients receiving immunosuppressive doses of corticosteroids should not be given live or live attenuated vaccines. The FDA granted this application fast track designation and priority review. The drug also received orphan drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases. The sponsor is receiving a rare pediatric disease priority review voucher under a program intended to encourage development of new drugs and biologics for the prevention and treatment of rare pediatric diseases. A voucher can be redeemed by a sponsor at a later date to receive priority review of a subsequent marketing application for a different product. This is the ninth rare pediatric disease priority review voucher issued by the FDA since the program began. 7

9 Emflaza is marketed by Marathon Pharmaceuticals of Northbrook, Illinois. DISEASE RELATED BREAKING NEWS Jeenatara Begum Assistant Professor GNIPST Middle East respiratory syndrome coronavirus (MERS-CoV) Saudi Arabia: (10 th February, 2017) Between 10 January and 3 February 2017 the National International Health Regulations Focal Point of Saudi Arabia reported seventeen (17) additional cases of Middle East Respiratory Syndrome (MERS) including four (4) fatal cases. Three (3) deaths among previously reported MERS cases (case no. 1 and 2 in DON published on 26 January 2017 and case no. 6 in DON published on 17 January 2017) were also reported. Read more UPCOMING EVENTS Workshop on Hands on Training on HPLC will be held at Indore Institute of Pharmacy, Indore 16 th to 17 th February, AICTE sponsored XXIII Quality Improvement Program for teachers of Pharmacy Colleges across the country on update on Trends in Pharmaceutical Sciences will be held at DIPSAR, New Delhi on 27 th February to 10 th March

10 DRUGS UPDATES FDA Approves Siliq (brodalumab) for Plaque Psoriasis: (15 th February, 2017) The U.S. Food and Drug Administration approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection. Read more CAMPUS NEWS Sardar Jodh Singh Trophy 2017: On 17 th February 2017 GNIPST participated in Sardar Jodh Singn Trophy 2017 and played the cricket match against Asansol Engineering College and GNIT. Annual Sports Meet 2017: On 14 th and 15 th February 2017 GNIPST organized Annual Sports Meet Congratulations to the following winner: Flat Race 100 m for Boys: 1 st : Suman Ghosh 2 nd : Arijit Mitra Thakur 3 rd : Arnab Ghosh Flat Race 100 m for Girls: 1 st : Moutan Roy 2 nd : Manpreet Kaur 3 rd : Kriti Prasad Flat Race 200 m for Boys: 1 st : Suman Ghosh 2 nd : Arnab Ghosh 3 rd : Abhiraj Pathak Flat Race 200 m for Girls: 9

11 1 st : Anjali Mondal 2 nd : Moutan Roy 3 rd : Kriti Prasad 3 Legged Race: 1 st : Aindrila Bhowmick Anjali Mondal 2 nd : Poulami Sarkar Pamolita Paul 3 rd : Renu Sha Sayani Das Long Jump for Boys: 1 st : Abu Sufian 2 nd : Saikat Bera 3 rd : Arijit Mitra Thakur Long Jump for Girls: 1 st : Sayani Das 2 nd : Aindrila Bhowmick 3 rd : Anjali Mondal Skipping for Girls: 1 st : Moutan Roy 2 nd : Aindrila Bhowmick 3 rd : Anjali Mondal Shot put for Boys: 1 st : Arijit Mitra Thakur 2 nd : Bishal Kr. Singh 3 rd : Abu Sufian Shot put for Girls: 1 st : Koyel Ghosh 2 nd : Aindrila Bhowmick 3 rd : Pamolita Paul 10

12 Discuss throw for Boys: 1 st : Arijit Mitra Thakur 2 nd : Monojit Dutta 3 rd : Bishal Kr. Singh Discuss throw for Girls: 1 st : Nasrina Mondal 2 nd : Aparupa Sinha 3 rd : Kriti Prasad Sack Race 50 m for Boys: 1 st : Sneham Sen 2 nd : Arijit Mitra Thakur 3 rd : Maruf Billa Akunji Sack Race 50 m for Girls: 1 st : Kriti Prasad 2 nd : Nasrina Mondal 3 rd : Moutan Roy Relay Race (4x100 m) for Boys: Winner: Sneham Sen Abhiraj Pathak Arijit Mitra Thakur Suman Ghosh Relay Race (4x100 m) for Girls: Winner: Kriti Prasad Sayani Das Nasima Mondal Sunanda Konar Go for Goal for Boys: 1 st : Abhiraj Pathak 2 nd : Arnab Ghosh 3 rd : Subhankar Malakar 11

13 Balance Race 100 m for Girls: 1 st : Aindrila Bhowmick 2 nd : Pamolita Paul 3 rd : Moutan Roy Tug of War (Boys): Winner: Monojit Dutta Kartik Koley Arijit Acharya Basit Fazal Aniket Upla Tug of War (Girls): Winner: Aparupa Sinha Priya Bardhan Roy Poulami Sarkar Pamolita Paul Moutan Roy Flat Race for /male Staff: 1 st : Dr. Subhendu Bandyopadhyay 2 nd : Debabrata Ghosh Dastidar 3 rd : Dipanjan Mondal Hit the Stamp for Male Staff: 1 st : Dipanjan Mondal 2 nd : Debabrata Ghosh Dastidar 3 rd : Dr. Asis Bala Hit the Stamp for Female Staff: 1 st : Anuranjita Kundu 2 nd : Prapti Chakraborty 3 rd : Rakhi Balance Race for Female Staff: 1 st : Moumita Chowdhury 2 nd : Priyanka Ray 12

14 3 rd : Jeenatara Begum Hari Bhanga for Female Staff: 1 st : Sumana Roy 2 nd : Priyanka Ray 3 rd : Rakhi Tug of War (Female Staff): Winner: Dr. Sumana Chatterjee Dr. Sriparna Kundu Sen Sumana Roy Jeenatara Begum Moumita Chowdhury Jaya Banerjee Satabdi Sunknowledge Pvt. Ltd.: Cngratulations to the students who got the job of Sonknowledge Pvt. Ltd. 1. Aishwarya Datta 2. Debjani Saha 3. Sayani Banerjee 4. Priya Dey 5. Anurag T K Baidya 6. Diptarco Singha 7. Soumyadeep Bhattachrya 8. Soumava Bhattacharya 9. Aniruddha Bhar 10. Dibyojyoti Chatterjee QUIZ organized by GNIDSR: Congratulations to Pratik Nandi and Bhaskar, who have acquired 2 nd position in quiz competition organized by GNIDSR. 13

15 Reminiscence 2017: On 12 th February, 2017 GNIPST celebrated Reunion programme. GPAT 2017: Congratulations to the students of GNIPST who have scored in GPAT Cognizant: Congratulations to the students who got the job of Cognizant NBA Accreditation: NBA has accreditated GNIPST. Debate competition: On 19 th November, 2016 our student Pratik Nandy and Dippoman Guha was participated in All India University debate Competition organized by Calcutta Debate Circle. International seminar 2016: International seminar on Global Advancement in Pharmaceutical research and startup organized by GNIPST in collaboration with IPGA was held on 22 nd October, 2016 at GNIPST auditorium. NBA visit: The experts of National Board of Accreditation or NBA will be going to visit GNIPST on 24 th September and 25 th September, Freshers welcome programme: On 12 th September GNIPST organized the Freshers welcome programme Kulrav 2k16. GNIPST Football Match 2016: On 31 st August and 1 st September GNIPST sports club organized a football match. The winner of the football match was B.Pharm 3 rd year. 14

16 Recent Trends in Pharmaceutical Research: A Science Awareness Programme comprising of seminar on Recent Trends in Pharmaceutical Research was organized by GNIPST in collaboration with National Academy of Science India (NASI) on 30 th august, 2016 from 2 pm to 4.30 pm at GNIPST auditorium. Plantation programme was also organized by Eco club. Dr. Hemanta Kumar Majumder, gave his valuable lecture on Modern Biology & its Evolution and Dr. Pijush K Das delivered his lecture on Site specific Drug Targeting Magic Bullet approach. World Photography Day celebration: On 19 th August 2016 GNIPST celebrated World Photography Day at Dakhineswar. Friendly Football Match: On 15 th August 2016 GNIPST organised a friendly football match with Alumni members. Farewell 2016: On 25 th May 2016 GNIPST celebrated the farewell programme for the final year students. Best of luck to all final year students for their future life. ALUMNI MEMBERS 2016: Congratulations to new Alumni Members of GNIPST. Placement Record 2016: SL NO COMPANY NAME NUMBER OF STUDENT APPEARED/APPLIED NUMBER OF STUDENT SELECTED JOB PROFILE 1 DR. LAL PATH LAB 64 7 Sales, Marketing and office assistant 2 APOLLO PHARMACY Hospital and retail chain pharmacist 15

17 3 ABBOTT INDIA Sales and Marketing 4 HETERO DRUGS (Waiting for final interview) Production, QC and QA 5 ERIS LIFE SCIENCES (Joined) Sales and Marketing 6 JUPITER PHARMACEUTICALS (Joined) Production, QC and QA 7 GOVT PHARMACIST 4 4 (Joined) Hospital Pharmacist 8 ALCHEMIST EYE HOSPITAL 9 OPTIVAL HEALTH SOLUTIONS PVT. LTD. (MEDPLUS) 2 2 (Waiting for final interview) Hospital Pharmacist Community Pharmacist 10 NESTLE INDIA LTD Nutrition Officer Trainee 11 LUPIN Sales and Marketing 12 GSK PHARMACEUTICAL LTD 13 OAK PHARMACEUTICAL (1 of them already joined) Sales and Marketing (Joined) Sales and Marketing IPA Bengal Pharma & Healthcare trust scholarship 2016: Congratulations to Rudradip Das, student of B.Pharm 3 rd year has been awarded IPA Bengal Pharma & Healthcare trust scholarship

18 Accreditation by NAAC: SL. NAME OF NO. THE INSTITUTE 01 Guru Nanak Institute of Pharmaceutical Science And Technology, Kolkata STATE West Bengal CGPA(out of scale 4) 2.70 B GRADE GPAT 2016 Result: The following B.Pharm. final year students have qualified, GPAT We congratulate them all. Aishika Datta Mainak Chatterjee Indira Saha Priyanka De Aheli Mukherjee Soumya Guha Debanjana Das Debalina Datta Evana Patra Himadrija Chatterjee IRIS 2016: GNIPST organized colllege fest IRIS 2016 from 11 th to 13 th March, Result of different events: Intracollege Quiz competition: 1 st : Arani Roy and Dipayan Nath 2 nd : Bhaskar Singha and Pratik Nandi Intracollege Painting competition: 1 st : Swagata Paul 17

19 2 nd : Aviraj Pathak 3 rd : Dippyoman Guha Group Dance Competition: Karma Group Intercollege Solo Dance Competition: 1 st : Monodipa Ghosh 2 nd : Aditya Paul (NIT) Antaksari Competition: 1 st : Sunanda and Aparupa 2 nd : Meghna and Joyita 3 rd : Arpita and Pami Intercollege Solo Singing Competition: 1 st : Arpita Sarkar 2 nd : Arvind Raj (Sudhir Chandra College) 3 rd : Priyam Mondal (Supreme College) Intercollege Band Competition: 1 st : D Errors 2 nd : Mukti 3 rd : GNIPST band Fashion: Best Male: Md. Nadeem Shah Best Female: Sweta Best Couple: Md. Nadeem Shah and Susmita Kar Blood donation Camp 2016: On 4 th March 2016 Social Service club and Alumni Association of GNIPST organized a Blood donation camp in association with Association of voluntary Blood Donars, West Bengal. National Assessment and Accreditation Council (NAAC): 18

20 A NAAC peer team completed a three-day inspection (17 th February to 19 th February, 2016) of GNIPST to evaluate its academic credibility and infrastructure on Friday. Saraswati Puja 2016: On 13 th February 2016 the students of GNIPST celebrated Saraswati Puja at GNIPST campus. STUDENTS SECTION WHO CAN ANSWER FIRST???? Identify the person: Answer of Previous Issue: 2 nd February Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students Section& answers of this Section at gnipstbulletin@gmail.com EDITOR S NOTE It is a great pleasure for me to publish the 1 st issue of 64 th Volume of GNIPST BULLETIN. All the followers of GNIPST BULLETIN are able to avail the bulletin through facebook account GNIPST bulletin I am very much thankful to all the GNIPST members and readers who are giving their valuable comments, encouragements and supports. I am also thankful to Dr. Abhijit Sengupta, Director 19

21 of GNIPST for his valuable advice and encouragement. Special thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar and Mr. Soumya Bhattacharya for their kind co-operation and technical supports. Thank you Mr. Soumya Bhattacharya for the questionnaires of the student section. An important part of the improvement of the bulletin is the contribution of the readers. You are invited to send in your write ups, notes, critiques or any kind of contribution for the forthcoming special and regular issue. ARCHIVE OTHERS: AICTE has sanctioned a release of grant under Research Promotion Scheme (RPS) during the financial year to GNIPST as per the details below: a. Beneficiary Institution: Guru Nanak Institution of Pharmaceutical Science & Technology. b. Principal Investigator: Dr. LopamudraDutta. c. Grant-in-aid sanctioned:rs. 16,25000/- only d. Approved duration: 3 years e. Title of the project: Screening and identification of potential medicinal plant of Purulia & Bankura districts of West Bengal with respect to diseases such as diabetes, rheumatism, Jaundice, hypertension and developing biotechnological tools for enhancing bioactive molecules in these plants. 20

22 Activity Clubs of GNIPST: Name of Club Member Faculty CULTURAL Ms. Priyanka Ray DEBATE AND EXTEMPORE Mr. Soumya Bhattacharya ECO Ms. Sumana Roy LITERARY AND PAINTING Ms. Jeenatara Begum PHOTOGRAPHY Ms. Sanchari Bhattacharya and Mr. Abir Koley SCIENCE AND INNOVATIVE Mr. Samrat Bose MODELLING SOCIAL SERVICES Dr. Asis Bala SPORTS Mr. Debabrata GhoshDastidar 21